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Chemotherapy treatment usually involves the delivery of fluorouracil (5-Fu) together with other
drugs through central venous catheters. Catheters and their connectors are increasingly coated (or
impregnated) with silver or argentic alloys/compounds. Complications such as broken catheters are
common, leading to additional suffering for patients and increased medical costs. Here, we uncover
a likely cause of such failure through a study of the surface chemistry relevant to chemotherapy
drug delivery, i.e. between 5-Fu and silver. We show that silver catalytically decomposes 5-Fu,
releasing HF as a product. This reaction compromises the efficacy of the treatment, and at the
same time, releases HF which is damaging to both patient and catheter. Our study not only reveals
an important reaction which has so far been overlooked, but additionally allows us to propose
that graphene coatings inhibit such a reaction and offer superior performance for cancer treatment
applications.
5-Fluorouracil (5-Fu) is one of the most commonly used
drugs in chemotherapy treatments [1–4]. 5-Fu acts to in-
hibit thymidine, a nucleoside required for DNA replica-
tion and necessary for cancer cells to reproduce [3]. The
administration of 5-Fu into the human body is generally
accomplished via a central venous catheter. Catheters
are made of polymeric materials such as polyurethane
and silicone [5] and they are prone to degradation when
in contact with bodily fluids or aggressive drugs such
as 5-Fu [6, 7]. Degradation can be reduced by apply-
ing protective coatings onto the internal and/or external
surfaces of the catheters [8, 9]. Among the materials
used for coating purposes, noble metals (i.e. silver and
argentic alloys [10–13]) are particularly common because
of their low reactivity and antimicrobial properties [14–
17]. Despite the efforts made to improve the quality of
the treatments of cancer and the life expectancy of the
patients, investigation of a possible chemical reaction be-
tween coating materials and the chemotherapeutic drug
itself is lacking (although some studies of the electronic
interaction exist, see for example Ref. 18). In this work,
we study the degradation of 5-Fu by silver surfaces, we
report that HF is formed as a product, and we demon-
strate graphene coatings to be an inert alternative.
RESULTS
We initially present an X-ray photoemission spec-
troscopy (XPS) investigation of ‘bulk-like’ 5-Fu. Al-
though XPS is a powerful technique for studying organic
molecules (including uracil [19]), to the best of our knowl-
edge no XPS studies of 5-Fu exist. Since the depth sensi-
tivity in an XPS experiment is limited by the mean-free-
path of the photoemitted electrons (typically ≈1 nm), a
4 nm thick film of 5-Fu is sufficiently thick to be con-
sidered bulk-like. Indeed, our XPS study reveals that
only the molecules, and not the underlying substrate,
contribute to the signal (the XPS technique and depth
sensitivity are represented in Fig. 1a, and an overview
XPS measurement in Fig. 1b). In our investigation of
this bulk-like film, we also measured the 1s core level
spectra for nitrogen, fluorine, oxygen and carbon at low
kinetic energy, and these results are summarized in Fig.
1c-f.
Quantitative analysis of the XPS data allows us to con-
firm the stoichiometry of the molecular film. 5-Fu is com-
posed of C, F, N and O in a ratio 4 : 1 : 2 : 2, and this is
in good agreement with the experimentally determined
abundance 4.6 : 1 : 2.2 : 1.8 (measured relative to F,
which is defined as unity). The multiple contributions to
the C1s core level indicate that carbon is present in mul-
tiple bonding configurations with dissimilar binding en-
ergies. Furthermore, we carried out a similar XPS study
on a bulk-like film prepared from powder (i.e. not ther-
mally evaporated in vacuum) to show that 5-Fu is not
damaged by evaporation (see supplementary material).
A thin film (≈0.7 nm) film of 5-Fu was also prepared on
an Ag substrate. XPS measurements (Fig. 2a) reveal that
a reaction takes place at body temperature (≈35 ◦C).
2Measurement were also performed at lower temperatures
in order to reduce the thermal energy available (i.e. to
facilitate observation of the intermediate steps of the re-
action and their approximate energy budget).
Our study reveals that already at -170 ◦C the N1s
core level undergoes a significant change from its bulk
form, reflecting a change in the N bonding configuration.
A new ‘reacted’ N1s core level component is observed
at larger binding energy, shifted 2.2 eV from the unre-
acted component. We propose that the reaction involves
breaking one of the N-H bonds with a subsequent H loss
from the molecule. Assuming that only one N-atom per
molecule is able to react, quantitative analysis of the N1s
components indicates that ≈80% of the molecules are
in the reacted form (Fig. 2d). The reaction is already
favourable at the lowest temperature studied (-170 ◦C),
and thus increasing the temperature is not seen to play
a significant role, as the reaction is completed far below
body temperature.
Analysis of the F1s peak also reveals that a reaction
FIG. 1. Photoemission spectroscopy of a bulk-like 5-Fu
sample: a, Schematic of the photoemission process and the
depth sensitivity of the experiment. b, An overview measure-
ment of the bulk-like 5-Fu sample (photon energy hν=800 eV,
temperature -170 ◦C). c-f, Detail of the F1s, O1s, N1s and
C1s regions respectively, measured with lower kinetic energy
and higher resolution. The raw experimental data (red) and a
fit to the data (blue). Details of the fit and of the quantitative
analysis are reported in the supplementary material.
is taking place – seen as a reduction of the F1s intensity,
indicating that fluorine is lost into the vacuum. Here the
reaction shows a strong temperature dependence (Fig.
2c); at low temperature, the loss is ≈57% (relative to the
bulk-like film), and as the temperature is increased to
body temperature and above, the loss is almost complete
(≈90%). The same behavior can also be observed by ex-
tracting the F1s/N1s intensity ratio (=0.5 for bulk 5-Fu)
which is reduced to ≈0 as the temperature is increased
(Fig. 2e).
Summarizing, we observe that 5-Fu in contact with
Ag gives rise to reactions which modify the bonding of
an N-atom in the 5-Fu molecule, and involves a massive
F loss under vacuum conditions. We postulate a possi-
ble reaction which is consistent with these observations
(Fig. 2b). Whilst the modification of the N-atom is al-
ready favourable with minimal thermal energy (i.e. low
temperature), the loss of F requires a moderate energy
budget - indicative of a reaction where the mobility of
the species on the surface plays a role. At body temper-
ature both of these reactions are favourable and the vast
majority of the molecules are seen to have reacted.
X-ray absorption spectroscopy (XAS) measurements
of 5-Fu on Ag also support the notion of a change in
the molecular pi-bonding configuration of the molecule
(Fig. 2f). Compared to the bulk-like sample, 5-Fu on Ag
shows additional features at lower photon energies, in the
energy range corresponding to a transition from the N1s
core level to an unoccupied pi⋆ orbital (indicated by the
green area in Fig. 2f). This result suggests that the pi-
bonding of an N-atom has been significantly modified,
but that a delocalised pi state still remains. This view
is consistent with the XPS inference of a silver-mediated
reaction involving the breaking of an N-H bond. For
both the bulk film and 5-Fu on Ag, the pi⋆ absorption
features are reduced at normal incidence (NI) relative to
the measurement at 45◦ incidence, indicating that the
molecules have a preference to lie flat on the substrate.
For the bulk film, the molecular orientation is broadly
consistent with the bulk crystal structure. For the thin
film 5-Fu on Ag, the molecular orientation is consistent
with STM measurements and the orientation expected
for the reacted species (see supplementary material for
the bulk crystal structure and STM measurements).
The reaction observed on the Ag surface is not seen on
graphene. Graphene is chosen because we expect it to
be chemically inert, and because it already attracts at-
tention as the ultimately thin protective coating [20–22].
However, its potential as a coating material in chemother-
apeutic drug delivery systems appears to have been en-
tirely overlooked. Graphene is a bio-compatible material
[23, 24] with low toxicity. In contrast to many metals,
the accidental release of small quantities of a graphene
coating into a patient is less concerning than a similar
release of alternative coating materials.
A thin film (≈0.7 nm) of 5-Fu on graphene was pre-
3FIG. 2. The reaction of 5-Fu with an Ag substrate: a, XPS measurements of the N1s and F1s core levels of bulk 5-Fu
(upper panel) and 5-Fu on Ag (lower panel). The green (orange) color indicates unreacted (reacted) components. Raw data
(red) and fits (blue) are shown. The reacted component of the N1s spectra appears at lower binding energy (≈2.2 eV with
respect to the unreacted component). Both F1s and N1s show a shift (due to a charge transfer induced by doping) indicated by
the dashed lines. The intensities of the core levels have been normalized to the synchrotron beam current and acquisition time.
The photo-ionization cross section has been considered for the quantitative analysis (see supplementary material). b, Schematic
of the proposed reaction. The atoms involved in the reaction have been highlighted. c, The proportion of F lost from the
surface. d, The proportion of 5-Fu molecules containing a reacted N atom. e, The F1s/N1s ratio as function of temperature. f,
Nitrogen XAS measurements at two different incidence angles for 5-Fu on Ag revealing a change in the pi-bonding as compared
to a bulk-like sample.
pared by thermal evaporation, following the same pro-
cedure as above. i.e., the only difference with the ex-
periment of 5-Fu on Ag is that a graphene substrate is
used in place of Ag. Temperature dependent XPS data
have also been acquired (Fig. 3c) and compared with that
from 5-Fu on Ag (Fig. 3b). Contrary to 5-Fu on Ag, the
chemotherapy molecules on graphene do not react at any
temperature; instead they are simply desorbed at moder-
ate temperatures. This observation supports the idea of
a weak interaction between graphene and 5-Fu since al-
ready at ≈55 ◦C the intact molecules have left the surface
and no N and F can be detected by XPS.
DFT calculations have also been performed which sup-
port our experimental findings. Fig. 4 shows four of the
steps of one possible 5-Fu+Ag reaction pathway. The
first step (i) involves the absorption of the molecule onto
the Ag(111) surface; it is seen to be weakly physisorbed,
and the total energy is lowered by ≈1 eV. In step ii, the
C-F bond and a C-H bond are broken, resulting in a small
increase in the total energy, but feasible even at low tem-
perature. H and F are liberated from the molecule and
stay bound to the Ag surface. In steps iii and iv, the H-
atoms which remain attached to the molecule fragment
rearrange, with negligible change in the energy. Finally,
in step v (not shown), H and F recombine and an HF
molecule is desorbed into vacuum. This last step requires
a moderate input of energy, and is consistent with the
measured temperature dependence.
To summarize, the molecules react at low temperature
and the bonding in the vicinity of one N-atom is mod-
ified with the macrocycle remaining intact. Although
H and F are already ‘lost’ from the 5-Fu molecule, the
HF recombination and liberation from the surface can-
not occur without a moderate amount of thermal energy.
In agreement with the observation of HF in our resid-
ual gas analysis, these calculations support HF, rather
than F2, as the favourable product (see the supplemen-
tary material for details of the residual gas analysis and
the energetics of the F2 formation).
An identical reaction pathway has been calculated for
5-Fu on graphene (see Fig. 4b). Contrary to the situation
for Ag, step ii requires a large energy input (≈3 eV),
which is prohibitive. In fact, it is much larger than the
absorption energy (step i), hence as the thermal energy
is increased, the intact molecule can desorb well before
it has the possibility to decompose.
The DFT calculation also confirms that the molecule
has a tendency to lie flat on both the Ag and graphene
4FIG. 3. The interaction of 5-Fu with graphene and
silver: a, Schematic represention of 5-Fu in contact with
Ag and graphene surfaces. b, Temperature dependent F1s
and N1s XPS measurements of 5-Fu on Ag. c, The same
temperature dependence for 5-Fu on graphene. No reaction
is seen, and at T=55 ◦C the molecules have been completely
desorbed, emphasising the weak interaction between 5-Fu and
graphene).
substrate - which is not surprising since molecules with
conjugated pi-systems typically show this tendency [25,
26]. The calculated orientation is consistent with the
orientation observed with XAS and STM. Finally, the
DFT calculation gives access to the binding energy of
the reaction species; the two inequivalent N-atoms in the
reacted molecular fragments have N1s components sepa-
rated by 1.7 eV (compared to a calculated N1s separation
of 0.4 eV for unreacted 5-Fu), this is in good agreement
with the experimentally determined value of 2.2 eV.
DISCUSSION
Using XPS, XAS and DFT (and supported by supple-
mentary techniques), we observed that a reaction takes
place for 5-Fu on silver which does not occur for 5-Fu
on graphene. Our experiments have been performed on
model surfaces in a well controlled ultrahigh vacuum en-
vironment (P ≤ 10−9 mbar). Although the experimental
conditions necessarily differ from in operando drug de-
livery (most notably, the lack of ionic solution), it is of
concern that an energetically favourable reaction exists
between 5-Fu and Ag, (with HF as a product) – espe-
cially when this reaction is readily avoided by choosing a
more suitable coating material.
We conclude that silver and argentic alloys might not
be a good choice for catheters delivering 5-Fu, since our
measurements reveal this chemotherapeutic agent to be
catalytically degradeble, with HF produced as a prod-
uct. Such a reaction occurring in a real catheter would
not only compromise the efficacy of the treatment, but
also create concern that HF is assimilated into the blood-
stream of a patient [27]. Furthermore, we speculate that
the presence of HF in the drug solution accounts, at least
partially, for the prevalent degradation of catheters and
their coatings. In the case of Ag coatings, this may re-
lease a considerable amount of Ag into the bloodstream,
also raising significant health concerns [28].
Since the potential effects of 5-Fu degradation are
so significant, it seems surprising that thorough stud-
ies of the relevant catheter surface chemistry have not
been carried out, and we believe that our study repre-
sents an important first step in rectifying this missing
knowledge. Furthermore, our study demonstrates more
generally that XPS, DFT and other surface chemistry
approaches are well suited to study the interaction of
chemotherapeutic drugs on relevant surfaces.
Graphene has already been suggested as an ex-
ternal coating for bio-medical applications, and we
therefore propose to use graphene for the internal
surfaces too. The fabrication of thin carbon-based
coatings is technologically realistic [29–31]; graphene
can even be grown directly on top of silver [32, 33].
We therefore believe that graphene coatings will offer
a vastly superior alternative to silver-based coatings,
and can return a societal benefit within a short timescale.
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Methods: The ‘powder’ sample was prepared by dis-
solving 5-Fu powder (>99%, Sigma-Aldrich, F6627-5G)
in de-ionised water, followed by dripping the solution
onto a tantalum sample plate and allowing it to dry un-
der atmospheric conditions. After drying, a thick white
powder layer was observed.
All other 5-Fu films were made by thermal evaporation
under ultra-high vacuum (UHV) conditions. The same 5-
Fu powder was placed in a tantalum crucible and heated
in-vacuum until it evaporated. The substrate was held in
front of the crucible and exposed to the molecular flux.
Prototype graphene samples were fabricated using
standard CVD instrumentation in NTNU’s NanoLab.
The high quality graphene sample was thermally grown
5FIG. 4. DFT calculated reaction pathway for 5-Fu on Ag: a Top view and side view of four of the reaction steps are
shown (labelled i-iv). Note; after step i, H- and F-remain bound to the surface, but are not shown in the figure. b The energy
diagram for this reaction pathway for both 5-Fu on Ag and 5-Fu on graphene. The initial energy is zero by definition, and the
absorption energy of 5-Fu on the two surfaces (step i) is almost identical. However, the energy of the decomposition (step ii)
is dramatically different.
on SiC with standard methods described in our previ-
ous work [34]. The Ag sample was a (111) single crystal
which had been prepared in-vacuum by cycles of sputter-
ing and annealing.
Photoemission measurements were carried out at
beamline D1011 at the MAX IV laboratory (Lund, Swe-
den). The thermally evaporated films were grown at the
beamline and measured without exposure to air.
Samples were prepared for STM analysis by similar
thermal evaporation in UHV.
Calculations were performed using Quantum Espresso
[35]. We employed the generalized gradient approxima-
tion (GGA) method PBE functional [36] with Van der
Waals correction [37]. An ultra soft pseudo-potential was
used [38]. Satisfactory convergences were obtained with
cutoffs of 70 Ry on the plane waves and 700 Ry on the
electronic density. These conditions were checked to get
a convergence of properties and lattice parameter of Ag
bulk of 4.15 A˚ (experimental value 4.09 A˚) [39] We used
the Γ point for the k-point sampling of the Brillouin zone.
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